Back to Cardiology
Cardiologyv1967_killipEvidence-Based

Killip Classification for Heart Failure

Quantifies heart failure severity in acute coronary syndrome (STEMI or NSTEMI) and predicts 30-day mortality. Based on physical examination findings to stratify risk in myocardial infarction patients.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
killip result
—classification
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Killip Classification for Heart Failure is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Clinical classification based on physical examination findings: Class I (no heart failure) → Class IV (cardiogenic shock)

Clinical Pearls & Practice Notes

  • Originally developed in 1967 before reperfusion therapy era
  • Still validated and predictive in modern era with PCI and thrombolytics
  • Simple bedside assessment requiring only physical examination
  • Useful for rapid risk stratification in emergency settings
  • Can guide treatment decisions including reperfusion therapy and mechanical support
  • Mortality rates have decreased since original study due to modern therapies
  • Should be used as part of full clinical assessment, not in isolation
  • Applies to both STEMI and NSTEMI patients

Evidence & Literature Citations

  1. Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967 Oct;20(4):457-64.
  2. Khot UN, Jia G, Moliterno DJ, Lincoff AM, Khot MB, Harrington RA, Topol EJ. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA. 2003 Oct 22;290(16):2174-81.
  3. Mello BH, Oliveira GB, Ramos RF, Lopes BB, Barros CB, Carvalho Ede O, et al. Validation of the Killip-Kimball classification and late mortality after acute myocardial infarction. Arq Bras Cardiol. 2014 Aug;103(2):107-17.
  4. DeGeare VS, Boura JA, Grines LL, O'Neill WW, Grines CL. Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2001 May 1;87(9):1035-8.

Score Interpretation Ranges

Tier 1≤ pts

No signs of congestion

Tier 2≤ pts

S3 and basal rales

Tier 3≤ pts

Acute pulmonary edema

Tier 4≤ pts

Cardiogenic shock

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.